Current Drug Therapy
Title: Editorial [Disparity in Pharmacotherapies]
Volume: 2 Issue: 2
Author(s): Joachin F. Wernicke
Affiliation:
Export Options
About this article
Cite this article as:
Wernicke F. Joachin, Editorial [Disparity in Pharmacotherapies], Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619077
DOI https://dx.doi.org/10.2174/157488507780619077 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functions and Mechanisms of Green Tea Catechins in Regulating Bone Remodeling
Current Drug Targets Application of Multimodal MR Imaging on Studying Alzheimer's Disease: A Survey
Current Alzheimer Research Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Current Alzheimer Research Prodrug Strategy for Enhancing Drug Delivery via Skin
Current Drug Discovery Technologies Structure, Functions and Selective Inhibitors of HDAC6
Current Topics in Medicinal Chemistry The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
Current Neuropharmacology Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Naturally Occurring Methyl Salicylate Glycosides
Mini-Reviews in Medicinal Chemistry Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer’s Disease
Current Alzheimer Research Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
Current Drug Targets Meet Our Editorial Board Member
Recent Patents on CNS Drug Discovery (Discontinued) The Synthetic Potential and Chemical Aspects of the Gewald Reaction: Application in the Preparation of 2-Aminothiophenes and Related Heterocycles
Current Organic Synthesis Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
Current Drug Targets Heart Disease Induced by AAS Abuse, Using Experimental Mice/Rats Models and the Role of Exercise-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Facts and Fiction: Cellular Models for High Throughput Screening for HIV-1 Reactivating Drugs
Current HIV Research Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives
Current Alzheimer Research Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology Physiology of Immune System: Regulation of Stem Cell Survival
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency
Pharmaceutical Nanotechnology